Evolent Health Company Top Insiders
EVH Stock | USD 11.25 0.34 2.93% |
Evolent Health's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Evolent Health suggests that almost all insiders are panicking. Evolent Health employs about 4.7 K people. The company is managed by 30 executives with a total tenure of roughly 118 years, averaging almost 3.0 years of service per executive, having 156.67 employees per reported executive.
Seth Blackley CEO Chief Executive Officer, Co-Founder, Director |
Frank Williams Chairman Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee |
Evolent Health's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-08-22 | Seth Blackley | Disposed 187904 @ 30 | View | ||
2023-12-05 | Seth Blackley | Disposed 141000 @ 26.54 | View |
Monitoring Evolent Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Evolent |
Evolent Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Evolent Health's future performance. Based on our forecasts, it is anticipated that Evolent will maintain a workforce of under 4700 employees by December 2024.Evolent Health's latest congressional trading
Congressional trading in companies like Evolent Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Evolent Health by those in governmental positions are based on the same information available to the general public.
2020-05-29 | Representative Greg Gianforte | Acquired $50K to $100K | Verify |
Evolent Health Management Team Effectiveness
The current Return On Tangible Assets is estimated to decrease to -0.15. The current Return On Capital Employed is estimated to decrease to -0.04. As of now, Evolent Health's Other Assets are increasing as compared to previous years. The Evolent Health's current Other Current Assets is estimated to increase to about 73.6 M, while Total Current Assets are projected to decrease to under 354.3 M. Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.The current Common Stock Shares Outstanding is estimated to decrease to about 70.4 M. The current Net Loss is estimated to decrease to about (18.1 M)
Evolent Health Workforce Comparison
Evolent Health is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 11,590. Evolent Health totals roughly 4,700 in number of employees claiming about 41% of equities under Health Care industry.
The company has Net Profit Margin of (0.03) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.03) %, which entails that for every $100 of revenue, it lost $0.03. Evolent Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Evolent Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2023-12-01 | 0.25 | 2 | 8 | 283,000 | 433,490 |
2023-09-01 | 0.1429 | 1 | 7 | 4,386 | 50,482 |
2023-06-01 | 0.6522 | 15 | 23 | 481,432 | 903,009 |
2023-03-01 | 0.5152 | 17 | 33 | 1,546,302 | 1,959,501 |
2022-12-01 | 0.3 | 3 | 10 | 295,000 | 590,000 |
2022-09-01 | 0.125 | 1 | 8 | 17,247 | 159,955 |
2022-06-01 | 9.0 | 9 | 1 | 50,076 | 3,860 |
2022-03-01 | 0.4167 | 10 | 24 | 453,809 | 966,247 |
2021-12-01 | 0.3846 | 5 | 13 | 183,405 | 390,000 |
2021-09-01 | 0.4762 | 20 | 42 | 175,318 | 402,716 |
2021-06-01 | 1.1818 | 13 | 11 | 119,417 | 125,052 |
2021-03-01 | 7.0 | 7 | 1 | 164,590 | 0.00 |
2020-09-01 | 0.5 | 1 | 2 | 10,000 | 20,000 |
2020-06-01 | 1.3333 | 8 | 6 | 268,114 | 99,530 |
2020-03-01 | 6.0 | 6 | 1 | 530,219 | 0.00 |
2019-09-01 | 0.4 | 2 | 5 | 22,200 | 80,222 |
2018-09-01 | 0.3103 | 9 | 29 | 245,440 | 735,559 |
2018-06-01 | 0.5625 | 9 | 16 | 58,672 | 3,189,979 |
2018-03-01 | 6.0 | 12 | 2 | 2,486,174 | 4,812,898 |
2017-09-01 | 0.3077 | 4 | 13 | 27,700 | 114,507 |
2017-06-01 | 0.403 | 27 | 67 | 8,034,433 | 20,455,695 |
2017-03-01 | 0.6071 | 17 | 28 | 4,713,444 | 11,742,278 |
2016-09-01 | 0.5238 | 11 | 21 | 2,037,829 | 10,427,023 |
2016-06-01 | 1.0 | 1 | 1 | 8,183 | 0.00 |
2015-12-01 | 2.0 | 2 | 1 | 12,954 | 0.00 |
2015-06-01 | 0.0227 | 1 | 44 | 2,000 | 13,768,760 |
Evolent Health Notable Stakeholders
An Evolent Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Evolent Health often face trade-offs trying to please all of them. Evolent Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Evolent Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dan McCarthy | CEO President | Profile | |
Seth Blackley | Chief Executive Officer, Co-Founder, Director | Profile | |
Frank Williams | Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee | Profile | |
Nicholas McGrane | Executive Vice President of Corporate Performance | Profile | |
John Johnson | Chief Financial Officer | Profile | |
Thomas Peterson | Chief Operating Officer | Profile | |
Steve Tutewohl | Chief Operating Officer | Profile | |
Bridget Duffy | Independent Director | Profile | |
Bruce Felt | Independent Director | Profile | |
Cheryl Scott | Lead Independent Director | Profile | |
David Farner | Director | Profile | |
Diane Holder | Director | Profile | |
Michael DAmato | Independent Director | Profile | |
Kim Keck | Independent Director | Profile | |
Jonathan JD | General Officer | Profile | |
Robert Cruz | Chief Officer | Profile | |
John MD | Chief Officer | Profile | |
Tunde Sotunde | Independent Director | Profile | |
MAAA FSA | Chief Officer | Profile | |
Emily Rafferty | Chief Officer | Profile | |
M Duffy | Independent Director | Profile | |
Craig Barbarosh | Independent Director | Profile | |
Jonathan Weinberg | General Counsel | Profile | |
Aammaad Shams | Interim Principal Accounting Officer and Corporate Controller | Profile | |
Jessica Somers | Sr Devel | Profile | |
Seth Frank | Vice Relations | Profile | |
Mark Mannion | Senior Finance | Profile | |
Peter Grua | Independent Director | Profile | |
Kali Beyah | Chief Officer | Profile | |
Jessica White | Chief Officer | Profile |
About Evolent Health Management Performance
The success or failure of an entity such as Evolent Health often depends on how effective the management is. Evolent Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Evolent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Evolent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.14) | (0.15) | |
Return On Capital Employed | (0.04) | (0.04) | |
Return On Assets | (0.04) | (0.04) | |
Return On Equity | (0.11) | (0.10) |
Evolent Health Workforce Analysis
Traditionally, organizations such as Evolent Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Evolent Health within its industry.Evolent Health Manpower Efficiency
Return on Evolent Health Manpower
Revenue Per Employee | 417.9K | |
Revenue Per Executive | 65.5M | |
Net Loss Per Employee | 24.1K | |
Net Loss Per Executive | 3.8M | |
Working Capital Per Employee | 2K | |
Working Capital Per Executive | 314.4K |
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |